TORON, INC (OTC: TRON) PROVIDES CORPORATE UPDATE REGARDING PENDING MERGER WITH IMEDSCAN CORPORATION
Toron Inc. to Merge With Disruptive Healthcare Technology Company MIAMI BEACH, FLORIDA – August 17, 2016 -
Toron, Inc (OTC Pink: TRON) provided its stockholders today with a corporate update regarding the pending merger with private company, iMedScan Corporation. Pursuant to the definitive Agreement and Plan of Merger entered into on March 30, 2016 iMedScan will become public through an alternative public offering or “APO” transaction with Toron. On March 21, 2016, in anticipation of the closing of the merger transaction during the third quarter of 2016, Fabrizio Bosticco, the Chief Executive Officer of iMedscan, was also named Chief Executive Officer, President and Director of Toron. iMedican is a healthcare project development and management company holding a proprietary technology that provides for the instant verification of a patient’s medical insurance. “iMedcan’s proprietary technology will generate a twenty-five (25%) reduction in patient insurance rejections or denials from insurance payors,” Bostico said. He continued, “changes in the healthcare industry have considerably lowered profit margins and increase the costs of healthcare to consumers; we believe our technology will create significant cost reductions that will benefit both insurers and insureds.” In March, 2016, iMedScan entered into an agreement with Acuant Corporation of Los Angeles, California to employ its proprietary, hosted scanning solution on patient’s driver’s licenses and insurance cards. Most recently, in June, 2016, iMedScan finalized a test program with Change America, formerly Emdeon Corpoation, utilizing an electronic data interchange for verifying and validating patients’ health insurance. “We estimate a fifty (50%) percent net profit recapture from each medical office that adopts our technology,” Bostico noted. Currently, in addition to traditional medical offices, iMedScan is focusing on the further development and commercialization of kiosk devices hosting the company’s scanning solution. About Toron, Inc. & iMedScan Corporation On March 30, 2016, Toron, Inc. entered into an definitive Agreement and Plan of Merger with iMedScan corporation, pursuant to which, upon closing, iMedScan will become a wholly-owned subsidiary of Toron. iMedscan Corporation is an innovative disruptive healthcare technology company focused on integrating access to electronic data interfaces (“EDI”) for healthcare providers and payor systems in a user friendly manner. iMedScan’s technology provides ease of use for patients by simplifying their check-in registration process, while at the same time reducing the healthcare providers’ administrative expenses and lost revenues by eliminating insurance rejections, denials or any incorrect results arising from erroneous or incomplete patient information verification. iMedScan’s proprietary iMedScan Connect and iMedScan EDI technologies will combine to create strong, recurring revenue for the company. Statements in this press release that are not historical fact may be deemed forwardlooking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. Although Toron, Inc believes the expectations reflected in any forward-looking statements are based on reasonable assumptions, Toron is unable to give any assurance that its expectations will be attained. Factors that could cause actual results to differ materially from expectations include the company’s ability meet the conditions necessary to, among other matters, obtain a public listing on a major national exchange. http://www.otcmarkets.com/otciq/ajax/showNewsReleaseDocumentById.pdf?id=21784
TRON: ALL SUPPLEMENTAL & RELATED DD LINKS
This is a post containing links to all of TRON's related Due Diligence that I have researched and created. Please take the time to review if you are a current Investor, interested or have any questions with regards to TRON, TRON's Merger/APO, TRON's Press Release, TRON's Reverse Split, etc.
DISCLAIMER: Some of the information is of my opinion and interpretation. If you have any questions feel free to ask myself or other members of TRON's board. Please conduct your own Due Diligence.
1.) TRON MERGER DD POST #9538
2.) INVESTOR'S: SUPPLEMENTAL DD ON TRON MERGER & APO POST #10113
3.) TRON: 15C2-11, R/S AND APO SUPPLEMENTAL DD POST #10302
INVESTORS: PRESS RELEASE VALIDATED BY ACUANT CORPORATION
***UPDATED TO PROVIDE SCREENSHOTS***
There has been speculation of TRON's Press Release being "fraudulent" due to Tracy's "questionable" past.
I tool the liberty of contacting Acuant Corporation, asking for verification of TRON's Press Release.
Acuant confirmed it.
Screenshots of the email chain is below.
****My initial email was sent via their "contact us" link on their website under "general inquiry" which will be linked below. The rest of the email chain is as follows:****
1st EMAIL, RESPONSE FROM ACUANT:
2nd EMAIL, REPLY TO ACUANT:
3rd EMAIL, REPLY TO ACUANT:
4th EMAIL, RESPONSE FROM ACUANT
Acuant confirmed the information regarding themselves in the PR, even going as far as stating "PatientTrac" who H Wayne Hayes owns.
I am also waiting on an email from Change Healthcare for confirmation of the PR.
Feel free to contact Acuant as well.
As of right now, TRON's Press Release is VALID.